[go: up one dir, main page]

TW200403059A - Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd - Google Patents

Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd Download PDF

Info

Publication number
TW200403059A
TW200403059A TW092116257A TW92116257A TW200403059A TW 200403059 A TW200403059 A TW 200403059A TW 092116257 A TW092116257 A TW 092116257A TW 92116257 A TW92116257 A TW 92116257A TW 200403059 A TW200403059 A TW 200403059A
Authority
TW
Taiwan
Prior art keywords
alkyl
represents hydrogen
formula
halogen
inhibitor
Prior art date
Application number
TW092116257A
Other languages
English (en)
Chinese (zh)
Inventor
Anders Lehmann
Michael Wrangstadh
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TW200403059A publication Critical patent/TW200403059A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02Sulfinic acids; Derivatives thereof
    • C07C313/04Sulfinic acids; Esters thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW092116257A 2002-06-20 2003-06-16 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd TW200403059A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0201940A SE0201940D0 (sv) 2002-06-20 2002-06-20 New combination II

Publications (1)

Publication Number Publication Date
TW200403059A true TW200403059A (en) 2004-03-01

Family

ID=20288298

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092116257A TW200403059A (en) 2002-06-20 2003-06-16 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd

Country Status (5)

Country Link
AR (1) AR040203A1 (sv)
AU (1) AU2003237739A1 (sv)
SE (1) SE0201940D0 (sv)
TW (1) TW200403059A (sv)
WO (1) WO2004000856A1 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ547204A (en) 2000-05-26 2008-01-31 Idenix Cayman Ltd Methods and compositions for treating flaviviruses and pestiviruses
AU2004243444A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
WO2005077345A1 (en) * 2004-02-03 2005-08-25 Astrazeneca Ab Compounds for the treatment of gastro-esophageal reflux disease
SE0402462D0 (sv) * 2004-10-08 2004-10-08 Astrazeneca Ab New process
US7566738B2 (en) 2004-11-03 2009-07-28 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
US7494985B2 (en) 2004-11-03 2009-02-24 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
WO2008033572A1 (en) 2006-09-15 2008-03-20 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
EP2531510B1 (en) 2010-02-01 2014-07-23 Novartis AG Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
WO2011095450A1 (en) 2010-02-02 2011-08-11 Novartis Ag Cyclohexyl amide derivatives as crf receptor antagonists
AR086554A1 (es) 2011-05-27 2014-01-08 Novartis Ag Derivados de la piperidina 3-espirociclica como agonistas de receptores de la ghrelina
MA20150428A1 (fr) 2012-05-03 2015-11-30 Novartis Ag Sel de l-malate de dérivés de 2,7-diaza-spiro[4.5]déc-7-yle et ses formes cristallines à titre d'agonistes des récepteurs de ghreline

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603408D0 (sv) * 1996-09-18 1996-09-18 Astra Ab Medical use
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9904507D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds
SE9904508D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds

Also Published As

Publication number Publication date
AU2003237739A1 (en) 2004-01-06
AR040203A1 (es) 2005-03-16
SE0201940D0 (sv) 2002-06-20
WO2004000856A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
ES2892954T3 (es) Derivados fluorados del ácido 3-(2-oxo-3-(3-(5,6,7,8-tetrahidro-1,8-naftiridin-2-il)propil)imidazolidin-1-il)propanoico y usos de los mismos
EP2458996B1 (en) Novel oral forms of a phosphonic acid derivative
US20090023712A1 (en) Pharmaceutical Compositions for the Treatment of Attention Deficit Hyperactivity Disorder Comprising Flibanserin
TW200403059A (en) Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd
CN110317192A (zh) 一类具有降解雄激素受体活性的化合物
JP2003523410A (ja) 治療薬
JP2021527031A (ja) セピアプテリンの薬学的に許容される塩
WO2016155545A1 (zh) 含氨磺酰基的1,2,5-噁二唑类衍生物、其制备方法及其在医药上的应用
WO2013081154A1 (ja) キナーゼ阻害剤の副作用低減剤
ES2672468T3 (es) Momelotinib deuterado
JP2014504258A (ja) 選択的プロトン共役葉酸輸送体および葉酸受容体ならびにGARFTaseおよび/または他の葉酸代謝酵素のインヒビター化合物、ならびにその使用方法
CN105246483A (zh) 用于γ-谷氨酰循环调节的方法和组合物
TWI287986B (en) Use of Epothilones for the treatment of the carcinoid syndrome
KR20040106422A (ko) 간암 및 다른 암 질병 치료용 에포틸론 유도체
JP5100619B2 (ja) ロキソプロフェン含有医薬製剤1
JP2024504424A (ja) 哺乳動物における体重減少を引き起こすための外因性ケトンエステルの使用
WO2004000855A1 (en) Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of gerd
CN109963853A (zh) 一类具有降解酪氨酸蛋白激酶jak3活性的化合物
JP2002293745A (ja) 慢性関節リウマチ治療剤
CN109879840B (zh) 4-哌嗪甲基-7-羟基苯并呋喃类化合物及其医药用途
JPH10212235A (ja) 抗腫瘍剤
ES2672326T3 (es) Analogos de tiazolidinona deuterados como agonistas para el receptor de la hormona folículo estimulante
WO2025113523A1 (zh) 熊果酸和多靶点酪氨酸激酶受体抑制剂的药物组合
CA3203125A1 (en) Endoxifen for treatment of ovarian cancer
CN116731305A (zh) 一种抗肿瘤大环内酯聚合物及其制备方法和应用